CDXS
Price
$2.42
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
218.45M
54 days until earnings call
VCEL
Price
$34.05
Change
+$0.38 (+1.13%)
Updated
Sep 5 closing price
Capitalization
1.72B
61 days until earnings call
Interact to see
Advertisement

CDXS vs VCEL

Header iconCDXS vs VCEL Comparison
Open Charts CDXS vs VCELBanner chart's image
Codexis
Price$2.42
Change-$0.00 (-0.00%)
Volume$722.31K
Capitalization218.45M
Vericel
Price$34.05
Change+$0.38 (+1.13%)
Volume$653.08K
Capitalization1.72B
CDXS vs VCEL Comparison Chart in %
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. VCEL commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and VCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CDXS: $2.42 vs. VCEL: $34.05)
Brand notoriety: CDXS and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 65% vs. VCEL: 110%
Market capitalization -- CDXS: $218.45M vs. VCEL: $1.72B
CDXS [@Biotechnology] is valued at $218.45M. VCEL’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, CDXS is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 4 TA indicator(s) are bullish while VCEL’s TA Score has 3 bullish TA indicator(s).

  • CDXS’s TA Score: 4 bullish, 5 bearish.
  • VCEL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both CDXS and VCEL are a bad buy in the short-term.

Price Growth

CDXS (@Biotechnology) experienced а -11.36% price change this week, while VCEL (@Biotechnology) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CDXS is expected to report earnings on Oct 30, 2025.

VCEL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($1.72B) has a higher market cap than CDXS($218M). VCEL YTD gains are higher at: -37.989 vs. CDXS (-49.266). VCEL has higher annual earnings (EBITDA): 16.2M vs. CDXS (-52.78M). VCEL has more cash in the bank: 117M vs. CDXS (66.3M). CDXS has less debt than VCEL: CDXS (69M) vs VCEL (99.8M). VCEL has higher revenues than CDXS: VCEL (249M) vs CDXS (57.2M).
CDXSVCELCDXS / VCEL
Capitalization218M1.72B13%
EBITDA-52.78M16.2M-326%
Gain YTD-49.266-37.989130%
P/E RatioN/A243.21-
Revenue57.2M249M23%
Total Cash66.3M117M57%
Total Debt69M99.8M69%
FUNDAMENTALS RATINGS
CDXS vs VCEL: Fundamental Ratings
CDXS
VCEL
OUTLOOK RATING
1..100
149
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
9989
PRICE GROWTH RATING
1..100
6486
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDXS's Valuation (38) in the Chemicals Specialty industry is somewhat better than the same rating for VCEL (89) in the Medical Specialties industry. This means that CDXS’s stock grew somewhat faster than VCEL’s over the last 12 months.

VCEL's Profit vs Risk Rating (72) in the Medical Specialties industry is in the same range as CDXS (100) in the Chemicals Specialty industry. This means that VCEL’s stock grew similarly to CDXS’s over the last 12 months.

VCEL's SMR Rating (89) in the Medical Specialties industry is in the same range as CDXS (99) in the Chemicals Specialty industry. This means that VCEL’s stock grew similarly to CDXS’s over the last 12 months.

CDXS's Price Growth Rating (64) in the Chemicals Specialty industry is in the same range as VCEL (86) in the Medical Specialties industry. This means that CDXS’s stock grew similarly to VCEL’s over the last 12 months.

CDXS's P/E Growth Rating (100) in the Chemicals Specialty industry is in the same range as VCEL (100) in the Medical Specialties industry. This means that CDXS’s stock grew similarly to VCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDXSVCEL
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASHTY301.2511.52
+3.98%
Ashtead Group PLC
WTLLF3.86N/A
N/A
Water Intelligence PLC
ACJJF2.44N/A
N/A
Acom Co. Ltd.
LSEB0.35N/A
N/A
LSEB CREATIVE CORP.
BWERY20.00N/A
N/A
BW Energy Limited

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
N/A
DNLI - CDXS
50%
Loosely correlated
+4.33%
PRAX - CDXS
49%
Loosely correlated
+1.65%
BEAM - CDXS
47%
Loosely correlated
+12.62%
CRSP - CDXS
47%
Loosely correlated
+4.02%
IPSC - CDXS
45%
Loosely correlated
+5.41%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with DNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+1.13%
DNA - VCEL
36%
Loosely correlated
-4.54%
FTRE - VCEL
35%
Loosely correlated
+10.66%
CDXS - VCEL
34%
Loosely correlated
N/A
PLRX - VCEL
34%
Loosely correlated
+14.11%
KYTX - VCEL
33%
Loosely correlated
+8.54%
More